blood-brain barrier

New research aims to make antibody drug delivery as precise and efficient as the antibodies themselves.

A specific blood-brain barrier protein may present a potential target for treatment-resistant epilepsy. 

Scientists and clinicians discussed their solutions for overcoming the challenge of getting past the blood-brain barrier in DDN’s first seminar.

By using extracellular vesicles to target specific neurons in the hypothalamus, scientists induced weight loss in a mouse model of obesity without altering its diet or exercise.

LIVE April 28th, 2022 at 10:00 AM
Researchers use ingenious strategies for breaking through the blood-brain barrier.

When a research question can’t be answered using the tools available, bioengineer Kiana Aran makes new tools. Recently, she developed a new type of brain-on-a-chip to answer questions about the blood brain barrier.

LIVE February 18th, 2022 at 10:00 AM ET
Careful study of the neurobiology of mental health leads to insights on the complexities of the human mind.

Scientists leverage the natural ability of antibodies to cross the blood-brain barrier and target proteins implicated in neurodegenerative disease.

By fusing a brain-targeted antibody with an antibody that protects neurons from degeneration, scientists developed a new class of drugs that can traverse the blood brain barrier, enabling potential new treatments for Parkinson’s disease, Alzheimer’s disease, and depression.

LIVE May 25th, 2021 at 10:30 AM ET
This webinar will discuss new drug delivery approaches to overcoming the blood-brain barrier.